Ye et al.24 reported that the intraperitoneal administration of 20 mg/kg/day niclosamide suppressed breast tumor growth without toxicity, increased the number of cleaved caspase-3-positive cells, and reduced lung metastasis in mice. This evidence concerns the gene CASP3 and breast neoplasm.